NCT01379066

Brief Summary

The Pulmonary Colonization Test is a non-invasive breath test for markers of lower respiratory tract infection, which may predict the probability of mycobacterial organisms in the lower respiratory tract. It consists of:

  • A breath collection apparatus for collection of volatile organic compounds in breath onto a sorbent trap and Tedlar bag, as well as for the collection of a separate sample of room air.
  • Analysis of the volatile organic compounds in breath and room air by short acoustic wave/gas chromatography.
  • Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of lower respiratory tract colonization and infection.
  • Analysis of the volatile organic compounds in sputum culture by short acoustic wave/gas chromatography. This study will test the hypothesis that the investigators can identify the presence of mycobacteria in an individual by sampling the breath of patients with active tuberculosis and by sampling "head space" above culture media of sputum provided. This study will test the hypotheses:
  • that the investigators can identify positive cultures for mycobacterium tuberculosis through sampling of the headspace above the cultures prior to standard laboratory culture identification
  • that the investigators can identify control of tuberculosis by sampling exhaled breath

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2009

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 23, 2011

Completed
Last Updated

August 13, 2014

Status Verified

August 1, 2014

Enrollment Period

4 months

First QC Date

June 21, 2011

Last Update Submit

August 12, 2014

Conditions

Keywords

Mycobacterium tuberculosisPulmonary tuberculosisElectronic noseGas chromatography

Outcome Measures

Primary Outcomes (1)

  • Identification of tuberculosis from bacterial plates

    Tuberculosis will be identified form culture plates by the volatile organic compound signature

    6 months

Study Arms (2)

Tuberculosis Patients

Suspected Tuberculosis patients

Control

Healthy volunteers

Eligibility Criteria

Age1 Year - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Tuberculosis patients will be enrolled through the Tuberculosis Specialty Clinic in Oxnard, Ca.

You may qualify if:

  • Suspected tuberculosis infection or disease
  • Positive tuberculosis skin test
  • Positive sputum culture for TB
  • X-rays indicated possible tuberculosis infection or disease
  • ability to give breath and sputum samples at regular intervals

You may not qualify if:

  • Heavy smoker
  • History of or active pulmonary disease other than tuberculosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Oxnard Specialty Clinic

Oxnard, California, 93033, United States

Location

Pediatric Diagnostic Center

Ventura, California, 93003, United States

Location

MeSH Terms

Conditions

Tuberculosis, Pulmonary

Condition Hierarchy (Ancestors)

TuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2011

First Posted

June 23, 2011

Study Start

August 1, 2009

Primary Completion

December 1, 2009

Study Completion

December 1, 2010

Last Updated

August 13, 2014

Record last verified: 2014-08

Locations